Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADVM | AMGN | GILD | CELG | ILMN |
| Company | Adverum Biotechnologies Inc | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 10.17 | 300.12 | 65.57 | 108.01 | 111.31 |
| High | 10.17 | 307.57 | 65.61 | 108.59 | 112.17 |
| Low | 9.60 | 298.89 | 64.76 | 107.27 | 108.54 |
| Last | 9.81 | 307.31 | 64.92 | 108.24 | 110.62 |
| Change | -0.53 | +7.01 | -0.54 | +0.11 | -2.20 |
| % Change | -5.13% | +2.33% | -0.82% | +0.10% | -1.95% |
| Volume | 200,500 | 2,859,500 | 5,134,900 | 191,230,496 | 2,848,800 |
| 20-Day Average Volume | 337,850 | 2,869,700 | 7,463,450 | 16,188,930 | 1,614,610 |
| Previous Close | 10.34 | 300.30 | 65.46 | 108.13 | 112.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.60 | 277.32 | 66.30 | 108.17 | 120.84 |
| 20-Day Raw Stochastic | 30.17% | 75.31% | 12.57% | 63.25% | 7.91% |
| 20-Day Relative Strength | 35.81% | 65.94% | 32.77% | 64.69% | 34.99% |
| Weighted Alpha | -29.66 | +32.33 | -21.04 | +46.30 | -45.55 |
| Today's Opinion | 40% Sell | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 56% Sell | 40% Buy | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 24% Sell | 8% Sell | 100% Sell | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.20% since 05/01/24 | +10.79% since 05/01/24 | -0.90% since 05/01/24 | -1.97% since 11/13/19 | -11.28% since 05/01/24 |
| Low | 9.50 on 05/02/24 | 274.90 on 05/02/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 108.54 on 05/08/24 |
| High | 10.84 on 05/07/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | -22.02% since 04/08/24 | +14.16% since 04/08/24 | -6.48% since 04/08/24 | +5.14% since 10/18/19 | -14.99% since 04/08/24 |
| Low | 8.76 on 04/29/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 108.54 on 05/08/24 |
| High | 12.72 on 04/09/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 135.26 on 04/09/24 |
| 3-Month | |||||
| %Chg | -50.20% since 02/08/24 | +4.23% since 02/08/24 | -12.03% since 02/08/24 | +13.63% since 08/20/19 | -22.82% since 02/08/24 |
| Low | 8.76 on 04/29/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 108.54 on 05/08/24 |
| High | 24.70 on 02/14/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 147.70 on 02/09/24 |
| 6-Month | |||||
| %Chg | +6.63% since 11/08/23 | +12.46% since 11/08/23 | -16.66% since 11/08/23 | +14.14% since 05/20/19 | -0.07% since 11/08/23 |
| Low | 7.40 on 12/29/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 29.70 on 02/08/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 214,627 | 161,091,424 | 81,502,736 | 77,035,920 | 17,972,226 |
| Shares Outstanding, K | 20,757 | 536,435 | 1,245,077 | 711,714 | 159,300 |
| Annual Sales | 3,600,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -117,170,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 1,076,000,000 |
| Last Quarter Net Income | -23,710,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | -126,000,000 |
| 60-Month Beta | 0.89 | 0.60 | 0.22 | 1.41 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.30 on 03/18/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.08 | 16.26 | 10.99 | 135.20 |